Lei Shi, PhD, Senior Vice President of Biointron, discusses: "Simplified and Humanized: Empowering Human Antibody Discovery with AbDrop™ Solution" during the Antibody Engineering & Therapeutics US 2024 conference in San Diego.
About the Speaker:
Lei Shi, PhD. is Senior Vice President of Biointron. He has more than 20 years of experience in antibody discovery. Previously Lei worked for a number of pharmaceutical and biotech companies such as Johnson & Johnson with increasing responsibilities, He completed his postdoc research at MGH and Harvard Medical School and has an Executive Masters degree from the University of Pennsylvania.
Our High-throughput Fully Human Antibody Discovery Platform integrates Cyagen’s HUGO-Ab™ mice with Biointron’s AbDrop™ microdroplet-based single B cell screening. This powerful combination accelerates the discovery and development of fully human antibodies, reducing the time from target identification to therapeutic candidate to just three months. Learn more about the service here.
Register now for a free download of the presentation slides.
AI is transforming antibody discovery, but better models only come from better d……
The antibody therapeutics sector is rapidly evolving, transitioning from traditi……
Biointron’s 2026 Lunch & Learn, held at CIC Cambridge on May 8, 2026, featured e……
ScientistとScience Exchangeとのご利用可能です。